David Bleakman
Hoofd Techniek/Wetenschap/O&O bij Redpin Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van David Bleakman
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Bleakman via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Executive Officer | |
CRISPR THERAPEUTICS AG | Biotechnology | Corporate Officer/Principal | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
HSBC Investment Bank Plc
HSBC Investment Bank Plc Regional BanksFinance Part of HSBC Holdings Plc, HSBC Investment Bank Plc provides stock broking services. The company is based in London, UK. | Regional Banks | Corporate Officer/Principal | |
State University of St. Petersburg | College/University | Undergraduate Degree | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Enso Ventures Ltd.
Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Chief Investment Officer | |
Vascular Flow Technologies Ltd.
Vascular Flow Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Indian Institute of Technology New Delhi | College/University | Graduate Degree | |
Rensselaer Polytechnic Institute | College/University | Doctorate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
EpiBone, Inc.
EpiBone, Inc. Medical SpecialtiesHealth Technology Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY. | Medical Specialties | Chairman | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Boston University | College/University | Masters Business Admin | |
SHATTUCK LABS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Hamburg | College/University | Undergraduate Degree | |
Image Analysis Ltd.
Image Analysis Ltd. Internet Software/ServicesTechnology Services Image Analysis Ltd. operates as an imaging clinical research organization. It supports optimal design and data management of clinical trials. The company was founded by Olga Kubassova in 2007 and is headquartered in London, the United Kingdom. | Internet Software/Services | Director/Board Member | |
KBP Biosciences USA, Inc.
KBP Biosciences USA, Inc. Miscellaneous Commercial ServicesCommercial Services KBP Biosciences engages in conducting biotechnological research to develop therapies for patients. The company was founded by Huang Zhenhua in and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
Scineuro Pharmaceuticals
Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Biotechnology | Consultant / Advisor | |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Consultant / Advisor | |
GSK PLC | Pharmaceuticals: Major | Chief Investment Officer | |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Equipment/Instruments | Director/Board Member | |
Licensing Executives Society | Corporate Officer/Principal | ||
Villanova University | College/University | Masters Business Admin | |
Advanced Viral Research Corp.
Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY. | Pharmaceuticals: Major | President | |
LaSalle University | College/University | Undergraduate Degree | |
Moscow State University Lomonosov | College/University | Undergraduate Degree | |
University of Oxford | College/University | Graduate Degree | |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Hornet Therapeutics Ltd.
Hornet Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Hornet Therapeutics Ltd. provides immune cell metabolism and cell therapy for cancer treatment. The company is based in London, UK and was founded in 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Araris Biotech AG
Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Ascend Gene & Cell Therapies Ltd.
Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Ascend Gene & Cell Therapies Ltd. is a gene and cell therapy manufacturing specialist that aims to create effective gene therapies to a world-class standard. The company is based in Altrincham, UK, and has subsidiaries in Germany. The British company focuses on constantly refining and flexing their approach and embracing opportunities to innovate to create therapies that change lives. Ascend has over $130m of funding as expert teams merge. The company has a solid platform that allows their team to do their best work and deliver unwavering quality. Timothy Michael Funnell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Alabama | College/University | Doctorate Degree | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member | |
Sonic Innovations, Inc.
Sonic Innovations, Inc. Medical SpecialtiesHealth Technology Sonic Innovations, Inc. provides digital hearing aids and hearing aid components. The company was founded by Douglas M. Chabries in may 1991 and is headquartered in Somerset, NJ. | Medical Specialties | Director/Board Member | |
Union Carbide Corp.
Union Carbide Corp. Chemicals: Major DiversifiedProcess Industries Union Carbide Corp. engages in the production of chemicals and polymers. The firm operates through the following geographical segments: United States, Asia Pacific and Rest of the World. Its products include polyethylene and polypropylene, ethylene glycol, isopropanol, ethyleneamines, biocides, surfactants, deicing and anti-icing fluids, amines, solution vinyl resins and polyethylene glycols. The company was founded on November 1, 1917 and is headquartered in Seadrift, TX. | Chemicals: Major Diversified | Chief Tech/Sci/R&D Officer | |
Story Chemical Corp. | Corporate Officer/Principal | ||
Infinity Discovery, Inc. | Director/Board Member | ||
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 31 |
Verenigd Koninkrijk | 12 |
Zwitserland | 3 |
Rusland | 3 |
Ierland | 2 |
Sectoraal
Health Technology | 19 |
Consumer Services | 12 |
Finance | 7 |
Commercial Services | 7 |
Electronic Technology | 3 |
Operationeel
Director/Board Member | 58 |
Corporate Officer/Principal | 14 |
Independent Dir/Board Member | 10 |
Undergraduate Degree | 6 |
Private Equity Investor | 4 |
Sterkste connecties
Insiders | |
---|---|
Anthony Evnin | 46 |
Brian McVeigh | 15 |
Andrey Kozlov | 12 |
Abhinav Shukla | 9 |
Dmitry Kuzmin | 9 |
Elma Hawkins | 6 |
- Beurs
- Insiders
- David Bleakman
- Bedrijfsconnecties